Pursuant to Regulation 30 and Regulation 33 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the Unaudited Financial Results on Standalone and Consolidated basis and Limited Review Report for the first quarter ended 30th June, 2024 which have been approved by the Board of Directors at its meeting held today i.e. 02nd August, 2024.

pdf

Ion Exchange (India) Ltd.

30 Jul 2024

421.60

-0.39%

Company Update

ION EXCHANGE (INDIA) LTD.-$ - 500214 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - …

BSE India

Pursuant to regulation 30(6) read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we wish to inform you that the Company will hold conference call with the Institutional Investor/Analyst on Monday, August 5, 2024 to discuss the Financial performance of the Company for the first quarter ended June 30, 2024.

pdf

Ion Exchange (India) Ltd.

25 Jul 2024

421.60

-0.39%

Corp. Note

ION EXCHANGE (INDIA) LTD.-$ - 500214 - Compliances-Reg. 39 (3) - Details of Loss of Certificate …

BSE India

Issuance of Duplicate Share Certificate to the Shareholder on Completion of necessary action.

pdf

Ion Exchange (India) Ltd.

19 Jul 2024

421.60

-0.39%

Board Meeting

ION EXCHANGE (INDIA) LTD.-$ - 500214 - Board Meeting Intimation for Consideration And Approval Of Unaudited …

BSE India

ION EXCHANGE (INDIA) LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/08/2024 ,inter alia, to consider and approve Pursuant to Regulation 29 (1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a Meeting of the Board of Directors of the Company will be held on Friday, 02nd August, 2024, inter-alia, to consider and approve the unaudited financial results for the first quarter ended 30th June, 2024.

pdf

Is Ion Exchange (India) Ltd. worth buying?

234 Votes:

Buy 79.06%

Sell 13.25%

Hold 7.69%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf